Phase 2 N=16 Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Primary: Overall Response — 1 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=240 Glove Perforation When Using Blunt Verses Sharp Needles in Cesarean Delivery
Cesarean Delivery · Glove Perforation
Primary: Surgical Glove Perforation. — 30; 30 Cases with a glove puncture
Phase 3 N=4,833 Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study
Pulmonary Embolism
Primary: Percentage of Participants With Symptomatic Recurrent Venous Thromboembolism [VTE] (i.e. the Composite of Recurrent Deep Vein Thrombosis [DVT] or Fatal or Non-fatal…
Phase 4 N=18 Effect of Weight and/or Obesity on Ethambutol Drug Concentrations
Obesity · Tuberculosis
Primary: Total Clearance of Ethambutol — 80.8 L/h
Phase 2 N=61 Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
Carcinoma, Small Cell
Primary: Overall Response Rate (ORR), the Percentage of Patients Who Experience an Objective Benefit From Treatment — 57 percentage of participants
Phase 4 N=292 Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
Influenza
Primary: Number of Participants Who Received Influenza Vaccine. — 250 participants
Phase 2 N=83 IV Glucose for Dehydration Treatment
Dehydration
Primary: Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis — 1.10; 2.39 mmol/L — p=0.0003
Phase 1 N=69 Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: High-density Lipoprotein Cholesterol (HDL-C) Concentration at Baseline — 54.30; 63.43 milligram per deciliter (mg/dL)
Phase 3 N=574 Comprehensive Add on Study in Japan
Diabetes Mellitus, Type 2
Primary: Incidence of Adverse Events (AEs) — 69; 55; 62; 114 Patients
Phase 2 N=82 Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
Atopic Dermatitis · Psoriasis
Primary: Change From Baseline on Day 21 in Relative Abundance of CAMP mRNA in Lesional and Non-Lesional Skin for Atopic Dermatitis (AD) Participants Who Received Oral Vitamin D3…
Phase 2 N=10 Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma
Skin Cancer · Metastatic Melanoma
Primary: Response — 0; 0; 8; 2 Participants
Phase 4 N=77 'Effect of CRT on Defibrillation Threshold Estimates' Study
Sudden Cardiac Death
Primary: Defibrillation Threshold Difference Obtained in Volts (V) Between Implant and 6 Months — 5.6 Volts
Phase 2 N=149 Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.
Asthma
Primary: Forced Expiratory Volume in One Second (FEV1) Peak Within 0-3 Hours Post-dose Response — 0.116; 0.255; 0.244; 0.304 Litre — p=<0.0001
N/A N=611 A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations
Vulvovaginal Candidiasis
Primary: The Test of Equivalence Between the Test and Reference Products Was Based on the Therapeutic Cure Rates at Visit 3/Test-of-Cure. — 73; 73; 16 participants
Phase 2 N=46 Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Invasive Aspergillosis
Primary: Safety and Tolerability of Caspofungin in Four Escalating Dosages in Adult Patients With Hematologic Malignancies and Proven or Probable Invasive Aspergillosis — 11; 12…